Belotero Balance® (injectable hyaluronic acid) [prescribing information]. Franksville, WI: Merz North America, Inc; Approved 2014.
Botox® Cosmetic (onabotulinumtoxinA) [prescribing information]. Irvine, CA: Allergan, Inc.; Approved 1989. Revised October 2017.
Bueller H. Ideal facial relationships and goals. Facial Plast Surg. 2018;34:458-465.
Dysport® (abobotulinumtoxinA) [prescribing information]. Fort Worth, TX: Galderma Laboratories; Approved 2009. Revised January 2019.
Fitgerald R, Carqueville J, Yang PT. An approach to structural facial rejuvenation with fillers in women. Int J Womens Dermatol. 2018;5:52-67.
Fraxel® Dual 1550/1927 Laser System [device information]. Hayward, CA: Solta Medical, Inc; Approved 2013.
Goodman GJ. The oval female facial shape—A study in beauty. Dermatol Surg. 2015;41:1375-1383.
Hexsel D, Soirefmann M, Porto MD, et al. Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg. 2012;38:207-214.
Juvéderm® Ultra Plus (hyaluronic acid) [prescribing information]. Santa Barbara, CA: Allergan, Inc; Approved 2016.
Juvéderm® Ultra XC (hyaluronic acid) [prescribing information]. Santa Barbara, CA: Allergan, Inc; Approved 2011.
Juvéderm Volbella® XC (hyaluronic acid) [prescribing information]. Irvine, CA: Allergan, Inc; Approved 2016.
Juvéderm® Vollure (hyaluronic acid) [prescribing information]. Irvine, CA: Allergan, Inc; Approved 2017.
Juvéderm® Voluma XC (hyaluronic acid with lidocaine) [prescribing information]. Irvine, CA: Allergan, Inc; Approved 2013.
King M. Management of ptosis. J Clin Aesthetic Dermatol. 2016;9:E1-E4.
Narukar VA, Cohen JL, Dayan S, et al. A comprehensive approach to multimodal facial aesthetic treatment: injection techniques and treatment characteristics from the HARMONY study. Dermatol Surg. 2016;42 Suppl 2:S177-179.
Radiesse® (hydroxylapatite gel) [prescribing information]. Franksville, WI: Merz Aesthetics. Approved 2014. Revised April 2015.
Restylane® Defyne (soldium hyaluronate) [prescribing information]. Fort Worth, TX: Galderma Laboratories, L.P.; Approved 2016.
Restylane® Lyft (hyaluronic acid) [prescribing information]. Fort Worth, TX: Galderma Laboratories, L.P.; Approved 2018.
Restylane® Refyne (soldium hyaluronate) [prescribing information]. Fort Worth, TX: Galderma Laboratories, L.P.; 2016.
Restylane® Silk (hyaluronic acid with lidocaine) [prescribing information]. Fort Worth, TX: Galderma Laboratories, L.P.; Approved 2013. Revised June 2014.
Revanesse Versa (hyaluronic acid) [prescribing information]. Aurora, Ontario, Canada: Prollenium Meidcal Technologies, Inc; Approved 2017.
Sculptra®/Sculptra® Aesthetic (poly-L-lactic acid) [prescribing information]. Fort Worth, TX: Galderma Laboratories, L.P.; Approved 2016.
Taub AF, Sarnaoff D, Gold M, et al. Effect of multisyringe hyaluronic acid facial rejuvenation on perceived age. Dermatol Surg. 2010;36:322-328.
Xeomin® (incobotulinumtoxinA) [prescribing information]. Frankfurt, Germany: Merz Pharmaceuticals, LLC; Approved 2019. Revised May 2019.

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Faculty

Mary P Lupo, MD

Clinical Professor of Dermatology
Tulane School of Medicine
Founder
Lupo Center for Aesthetic and General Dermatology
New Orleans, Louisiana

Disclosures

Disclosure: Mary P. Lupo, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan; Evolus; Ortho; Recros; Revision.
Served as a speaker or a member of a speakers bureau for: Cutera; Evolus; Lumenis.
Received grants for clinical research from: Allergan; Endo; Evolus; Merz ChemoCentryx; Ortho; Revance; Synteract.
Owns stock, stock options, or bonds from: Top MD Evolus.

Amy Taub, MD

Assistant Professor of Dermatology
Northwestern Feinberg School of Medicine
Chicago, Illinois
Founder
Advanced Dermatology
Lincolnshire, Illinois

Disclosures

Disclosure: Amy F. Taub, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan; Endo Pharmaceuticals; Evolus; Hydrafacial; MediCell Technologies; Merz; XoGlo.
Served as a speaker or a member of a speakers bureau for: Allergan; Candela; Cutera; MediCell Technologies; Solta.
Received grants for clinical research from: Allergan; Galderma; Revance.
Owns stock, stock options, or bonds from: MediCell Technologies; Skinfo; SkinQRI.

Steven Yoelin, MD

Private Practice
Newport Beach, California

Disclosures

Disclosure: Steve Yoelin, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan; Endo; Sinclair.
Served as a speaker or a member of a speakers bureau for: Allergan.
Received grants for clinical research from: Allergan; Endo; Merz.

Editor

Briana Betz, PhD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Briana Betz, PhD, has disclosed no relevant financial relationships.

CME/CE Reviewer, Nurse Planner

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CME / ABIM MOC / CE

The Aesthetic Gameshow: How Would you Approach These Patients?

Authors: Amy F. Taub, MD; Mary P. Lupo, MD; Steve Yoelin, MD
CME / ABIM MOC / CE Released: 5/19/2020
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 5/19/2021, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for dermatologists, plastic surgery & aesthetic medicine practitioners, PCPs, and nurses.

The goal of this activity is to present different expert viewpoints on aesthetic strategies for facial enhancement.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Ideal facial shape and architecture
Have greater competence related to
- The use of filler options and techniques that are most optimal for different facial areas
- Implementation of combination minimally invasive techniques for facial enhancement

Disclosures

Faculty

Mary P Lupo, MD

Clinical Professor of Dermatology
Tulane School of Medicine
Founder
Lupo Center for Aesthetic and General Dermatology
New Orleans, Louisiana

Disclosures

Disclosure: Mary P. Lupo, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan; Evolus; Ortho; Recros; Revision.
Served as a speaker or a member of a speakers bureau for: Cutera; Evolus; Lumenis.
Received grants for clinical research from: Allergan; Endo; Evolus; Merz ChemoCentryx; Ortho; Revance; Synteract.
Owns stock, stock options, or bonds from: Top MD Evolus.

Amy Taub, MD

Assistant Professor of Dermatology
Northwestern Feinberg School of Medicine
Chicago, Illinois
Founder
Advanced Dermatology
Lincolnshire, Illinois

Disclosures

Disclosure: Amy F. Taub, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan; Endo Pharmaceuticals; Evolus; Hydrafacial; MediCell Technologies; Merz; XoGlo.
Served as a speaker or a member of a speakers bureau for: Allergan; Candela; Cutera; MediCell Technologies; Solta.
Received grants for clinical research from: Allergan; Galderma; Revance.
Owns stock, stock options, or bonds from: MediCell Technologies; Skinfo; SkinQRI.

Steven Yoelin, MD

Private Practice
Newport Beach, California

Disclosures

Disclosure: Steve Yoelin, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan; Endo; Sinclair.
Served as a speaker or a member of a speakers bureau for: Allergan.
Received grants for clinical research from: Allergan; Endo; Merz.

Editor

Briana Betz, PhD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Briana Betz, PhD, has disclosed no relevant financial relationships.

CME/CE Reviewer, Nurse Planner

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For Nurses

Awarded 0.5 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Dermatology

CME / ABIM MOC / CE

The Aesthetic Gameshow: How Would you Approach These Patients?

Authors: Amy F. Taub, MD; Mary P. Lupo, MD; Steve Yoelin, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 5/19/2020

Valid for credit through: 5/19/2021, 11:59 PM EST

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

Download Now

CME / ABIM MOC / CE Information

Activity Transcript

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

References

Faculty and Disclosures

Faculty

Mary P Lupo, MD

Amy Taub, MD

Steven Yoelin, MD

Editor

Briana Betz, PhD

CME/CE Reviewer, Nurse Planner

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

CME / ABIM MOC / CE

The Aesthetic Gameshow: How Would you Approach These Patients?

Target Audience and Goal Statement

Disclosures

Faculty

Mary P Lupo, MD

Amy Taub, MD

Steven Yoelin, MD

Editor

Briana Betz, PhD

CME/CE Reviewer, Nurse Planner

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

The Aesthetic Gameshow: How Would you Approach These Patients?